BackAimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Overview

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Total Current Liabilities

Track Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's total current liabilities ($3.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$3.52M
108.70% YoYΔ $1.83M vs prior year quarter

Peer average

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Total Current Liabilities History

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 vs. peers: Total Current Liabilities Comparison

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 (AFJKR) FAQ

The latest total current liabilities for AFJKR is $3.5M as of March 2026. That compares with $1.7M in the prior-year period — up 108.7% year over year. Investors often review this figure alongside Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's historical trend and sector peers before judging valuation or financial health.

Over the past year, AFJKR's total current liabilities moved from $1.7M to $3.5M — a 108.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's operating scale or balance-sheet position.

A total current liabilities figure of $3.5M for AFJKR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting AFJKR's total current liabilities ($3.5M), review year-over-year change from $1.7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.